Allogeneic peripheral blood progenitor cell transplantation: Analysis of short-term engraftment and acute GVHD incidence in 33 cases

Bone Marrow Transplantation

Volumn 18, Issue 1, 1996, Pages 35-40

  Urbano Ispizua, A ^a   Solano, C ^b   Brunet, S ^c   Hernandez F ^d   Sanz, G ^e   Alegre, A ^f   Petit, J ^g   Besalduch, J ⁱ   Vivancos, P ^j   Diaz Ma ^f   Moraleda, J M ^h   Carreras, E ^a   Ojeda, E ^d   De La Rubia, J ^e   Benet, I ^b   Domingo Albos A ^c   Garcia Conde J ^b   Rozman, C ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL DURAN I REYNALS   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^j Institut Clinica Corachan   (Spain)

more..

Author keywords

Allogeneic transplantation; Peripheral blood progenitor cells

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; MELPHALAN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BONE PAIN; CELL COUNT; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

ACTUARIAL ANALYSIS; ACUTE DISEASE; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BONE MARROW; CATHETERIZATION, CENTRAL VENOUS; CHILD; CYCLOSPORINE; FEMALE; FILGRASTIM; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; METHOTREXATE; MIDDLE AGED; NEUTROPHILS; PLATELET COUNT; RECOMBINANT PROTEINS; RETREATMENT; RETROSPECTIVE STUDIES; SAFETY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 9544241334     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gianni AN, Bregni N, Stern AC et al. Granulocyte-macrophage colony stimulating factor to harvest circulating hemopoietic stem cells for autotransplantation. Lancet 1990; 3: 580-585.
2. Sheridan WP, Glenn Begley C, Jurttner CA et al. Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-644.
3. Goldman J. Peripheral blood stem cells for allografting. Blood 1995; 85: 1413-1415.
4. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood-derived, T-cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643-646.
5. Russell JA, Luider J, Weaver M et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995; 15: 111-115.
6. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
7. Laporte JPh, Lesage S, Douay L et al. Allogeneic transplantation with peripheral blood hematopoietic progenitors mobilized with G-CSF. Blood 1994; 84 (Suppl. 1): 90a.
8. Korbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659-1665.
9. Oblon DJ, Paul S, Oblon R, Yankee R. Allogeneic peripheral blood stem cell transplant. Blood 1994; 84 (Suppl. 1): 94a.
10. Majolino I, Buscemi F, Scimé R et al. G-CSF mobilized PBSC for allogeneic transplantation. Blood 1994; 84 (Suppl. 1): 92a.
11. Azevedo WM, Aranha FJP, Gonvea JV et al. Allogeneic transplantation for hematological malignancies using G-CSF mobilized, non cryopreserved, unmanipulated peripheral blood stem cells. Blood 1994; 84 (Suppl. 1): 703a.
12. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995; 85: 1655-1658.
13. Bacigalupo A, Majolino I, van Lint S et al. Transplantation of rh-G-CSF mobilized allogeneic peripheral blood cells from HLA identical sibling donors. Bone Marrow Transplant 1995; 15 (Suppl. 2): S5.
14. Link H, Arseniev L, Bähre O et al. Transplantation of allogeneic peripheral blood progenitor cells alone or in addition to bone marrow. Bone Marrow Transplant 1995; 15 (Suppl. 2): S5.
15. Potter MN, Pamphilon DH, Cornish JM et al. Related and unrelated donor PBSC allografting. Bone Marrow Transplant 1995; 15 (Suppl. 2): S28.
16. Urbano-Ispizua A, Carreras E, Sierra J et al. Whether methotrexate administration for GVHD prophylaxis significantly delay the engraftment in allogeneic peripheral blood progenitor cell transplantation. Blood 1995; 86: 836-837.
17. Rozman C, Urbano-Ispizua A, Carreras E et al. Allogeneic transplants with peripheral blood progenitor cells: a report of six cases. Leuk Lymphoma 1996; 20: 471-474.
18. Martínez JA, Picón I, Carral A et al. Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse. Bone Marrow Transplant 1995; 15: 149-151.
19. Dixon WJ, Brown MB, Engelman L et al. BMDP Statistical Software. University California Press: Berkeley, 1988.
20. Russell NH, Hunter AE. Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant 1994; 13: 353-355.
21. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981-1984.
22. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-613.
23. Kinniburgh D, Russell NH. Comparative study of CD34 positive cells and subpopulations in human umbilical cord blood and bone marrow. Bone Marrow Transplant 1993; 12: 489-494.
24. Majolino I, Aversa F, Bacigalupo A et al. Allogeneic transplants of rhG-CSF mobilized peripheral blood stem cells (PBSC) from normal donors. Haematologica 1995; 80: 40-43.
25. Harada M. Allogeneic peripheral blood stem cell transplantation is coming of age. Int J Haematol 1995; 62: 1-5.
26. Nademanee A, Sniecinski I, Schmidt GM et al. High-dose therapy followed by autologous peripheral-blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 1994; 12: 2176-2186.
27. Teshima H, Ishikawa J, Kitayama H. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study. Exp Hematol 1989; 17: 853-858.
28. Gisselbrecht C, Prentice HG, Bacigalupo A et al. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet 1994; 343: 696-700.
29. DiPersio J, Martin B, Abboud C et al. Allogeneic BMT using bone marrow and CD34-selected mobilized PBPC; comparison to BM alone and mobilized PBPC alone. Blood 1994; 82 (Suppl. 1): 91a.
30. Bensinger WI, Demirer T, Rowley S, Buckner CD. Factors predictive of rapid engraftment after peripheral blood stem cell infusions. Bone Marrow Transplant 1995; 15 (Suppl. 3): 583-585.
31. Haas R, Witt B, Möhle R et al. Sustained long term hematopoiesis after myeloablative therapy with peripheral blood progenitor cells support. Blood 1995; 82: 3754-3761.
32. Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-341.
33. Schwartzberg LS, Birch R, Blanco R et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 1993; 11: 369-374.
34. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-2846.
35. Baumann I, Testa NG, Lange C et al. Haemopoietic cells mobilised into the circulating by lenogastrim as alternative to bone marrow for allogeneic transplants. Lancet 1993; 341: 369.
36. Molineux G, Pojda Z, Hamson I et al. Transplantation potential of peripheral blood stem cells induced by colony-stimulating factor. Blood 1990; 76: 2153-2158.
37. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-3057.
38. Briones J, Urbano-Ispizua A, Rozman C et al. Study of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR amplification of short tandem repeats. Ann Hematol 1996; (in press).
39. Storb R, Pepe M, Deeg HJ et al. Long-term follow up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. Blood 1992; 80: 560-561.